Data as of 10:38am ET
| +0.26 / +0.70%|
The 3 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 60.00, with a high estimate of 66.00 and a low estimate of 51.50. The median estimate represents a +61.07% increase from the last price of 37.25.
The current consensus among 3 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.